Kirill Volynski, PhD - Publications

Affiliations: 
UCL Institute of Neurology, London, England, United Kingdom 
Area:
Presynaptic calcium, exocytosis

25/40 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Chamberland S, Timofeeva Y, Evstratova A, Norman CA, Volynski K, Tóth K. Slow-decaying presynaptic calcium dynamics gate long-lasting asynchronous release at the hippocampal mossy fiber to CA3 pyramidal cell synapse. Synapse (New York, N.Y.). e22178. PMID 32598500 DOI: 10.1002/Syn.22178  0.47
2020 Tyurikova O, Zheng K, Nicholson E, Timofeeva Y, Semyanov A, Volynski K, Rusakov DA. Fluorescence lifetime imaging reveals regulation of presynaptic Ca by glutamate uptake and mGluRs, but not somatic voltage in cortical neurons. Journal of Neurochemistry. PMID 32418206 DOI: 10.1111/Jnc.15094  0.378
2020 Tagliatti E, Bello OD, Mendonça PRF, Kotzadimitriou D, Nicholson E, Coleman J, Timofeeva Y, Rothman JE, Krishnakumar SS, Volynski KE. Synaptotagmin 1 oligomers clamp and regulate different modes of neurotransmitter release. Proceedings of the National Academy of Sciences of the United States of America. PMID 32015138 DOI: 10.1073/pnas.1920403117  0.322
2018 Bello OD, Jouannot O, Chaudhuri A, Stroeva E, Coleman J, Volynski KE, Rothman JE, Krishnakumar SS. Synaptotagmin oligomerization is essential for calcium control of regulated exocytosis. Proceedings of the National Academy of Sciences of the United States of America. PMID 30038018 DOI: 10.1073/Pnas.1808792115  0.422
2018 Chamberland S, Timofeeva Y, Evstratova A, Volynski K, Tóth K. Action potential counting at giant mossy fiber terminals gates information transfer in the hippocampus. Proceedings of the National Academy of Sciences of the United States of America. PMID 29946034 DOI: 10.1073/Pnas.1720659115  0.449
2018 Volynski KE, Krishnakumar SS. Synergistic control of neurotransmitter release by different members of the synaptotagmin family. Current Opinion in Neurobiology. 51: 154-162. PMID 29886350 DOI: 10.1016/j.conb.2018.05.006  0.307
2016 Vivekananda U, Novak P, Volynski K, Kullmann D. Modulation of axonal signalling in type 1 episodic ataxia The Lancet. 387. DOI: 10.1016/S0140-6736(16)00491-8  0.303
2015 Timofeeva Y, Volynski KE. Calmodulin as a major calcium buffer shaping vesicular release and short-term synaptic plasticity: facilitation through buffer dislocation. Frontiers in Cellular Neuroscience. 9: 239. PMID 26190970 DOI: 10.3389/fncel.2015.00239  0.376
2013 Ermolyuk YS, Alder FG, Surges R, Pavlov IY, Timofeeva Y, Kullmann DM, Volynski KE. Differential triggering of spontaneous glutamate release by P/Q-, N- and R-type Ca2+ channels. Nature Neuroscience. 16: 1754-63. PMID 24185424 DOI: 10.1038/nn.3563  0.316
2013 Song I, Volynski K, Brenner T, Ushkaryov Y, Walker M, Semyanov A. Different transporter systems regulate extracellular GABA from vesicular and non-vesicular sources. Frontiers in Cellular Neuroscience. 7: 23. PMID 23494150 DOI: 10.3389/Fncel.2013.00023  0.593
2013 Spillane J, Ermolyuk Y, Volynski K, Kullmann D. LAMBERT EATON MYASTHENIC SYNDROME ANTIBODIES DECREASE SYNAPTIC VESICLE EXOCYTOSIS IN NEURONAL CULTURES Journal of Neurology, Neurosurgery & Psychiatry. 84: e2.151-e2. DOI: 10.1136/Jnnp-2013-306573.35  0.348
2012 Ermolyuk YS, Alder FG, Henneberger C, Rusakov DA, Kullmann DM, Volynski KE. Independent regulation of basal neurotransmitter release efficacy by variable Ca²+ influx and bouton size at small central synapses. Plos Biology. 10: e1001396. PMID 23049481 DOI: 10.1371/Journal.Pbio.1001396  0.311
2011 Silva JP, Lelianova VG, Ermolyuk YS, Vysokov N, Hitchen PG, Berninghausen O, Rahman MA, Zangrandi A, Fidalgo S, Tonevitsky AG, Dell A, Volynski KE, Ushkaryov YA. Latrophilin 1 and its endogenous ligand Lasso/teneurin-2 form a high-affinity transsynaptic receptor pair with signaling capabilities. Proceedings of the National Academy of Sciences of the United States of America. 108: 12113-8. PMID 21724987 DOI: 10.1073/Pnas.1019434108  0.672
2009 Silva JP, Lelianova V, Hopkins C, Volynski KE, Ushkaryov Y. Functional cross-interaction of the fragments produced by the cleavage of distinct adhesion G-protein-coupled receptors. The Journal of Biological Chemistry. 284: 6495-506. PMID 19124473 DOI: 10.1074/Jbc.M806979200  0.659
2006 Thalhammer A, Rudhard Y, Tigaret CM, Volynski KE, Rusakov DA, Schoepfer R. CaMKII translocation requires local NMDA receptor-mediated Ca2+ signaling. The Embo Journal. 25: 5873-83. PMID 17124502 DOI: 10.1038/Sj.Emboj.7601420  0.428
2005 Liu J, Wan Q, Lin X, Zhu H, Volynski K, Ushkaryov Y, Xu T. Alpha-latrotoxin modulates the secretory machinery via receptor-mediated activation of protein kinase C. Traffic (Copenhagen, Denmark). 6: 756-65. PMID 16101679 DOI: 10.1111/J.1600-0854.2005.00313.X  0.714
2004 Volynski KE, Silva JP, Lelianova VG, Atiqur Rahman M, Hopkins C, Ushkaryov YA. Latrophilin fragments behave as independent proteins that associate and signal on binding of LTX(N4C). The Embo Journal. 23: 4423-33. PMID 15483624 DOI: 10.1038/Sj.Emboj.7600443  0.649
2004 Ushkaryov YA, Volynski KE, Ashton AC. The multiple actions of black widow spider toxins and their selective use in neurosecretion studies. Toxicon : Official Journal of the International Society On Toxinology. 43: 527-42. PMID 15066411 DOI: 10.1016/j.toxicon.2004.02.008  0.719
2003 Volynski KE, Capogna M, Ashton AC, Thomson D, Orlova EV, Manser CF, Ribchester RR, Ushkaryov YA. Mutant alpha-latrotoxin (LTXN4C) does not form pores and causes secretion by receptor stimulation: this action does not require neurexins. The Journal of Biological Chemistry. 278: 31058-66. PMID 12782639 DOI: 10.1074/Jbc.M210395200  0.729
2003 Capogna M, Volynski KE, Emptage NJ, Ushkaryov YA. The alpha-latrotoxin mutant LTXN4C enhances spontaneous and evoked transmitter release in CA3 pyramidal neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 4044-53. PMID 12764091  0.717
2001 Ashton AC, Volynski KE, Lelianova VG, Orlova EV, Van Renterghem C, Canepari M, Seagar M, Ushkaryov YA. alpha-Latrotoxin, acting via two Ca2+-dependent pathways, triggers exocytosis of two pools of synaptic vesicles. The Journal of Biological Chemistry. 276: 44695-703. PMID 11572875 DOI: 10.1074/Jbc.M108088200  0.722
2000 Volynski KE, Meunier FA, Lelianova VG, Dudina EE, Volkova TM, Rahman MA, Manser C, Grishin EV, Dolly JO, Ashley RH, Ushkaryov YA. Latrophilin, neurexin, and their signaling-deficient mutants facilitate alpha -latrotoxin insertion into membranes but are not involved in pore formation. The Journal of Biological Chemistry. 275: 41175-83. PMID 11024019 DOI: 10.1074/Jbc.M005857200  0.729
2000 Ashton AC, Rahman MA, Volynski KE, Manser C, Orlova EV, Matsushita H, Davletov BA, van Heel M, Grishin EV, Ushkaryov YA. Tetramerisation of alpha-latrotoxin by divalent cations is responsible for toxin-induced non-vesicular release and contributes to the Ca(2+)-dependent vesicular exocytosis from synaptosomes. Biochimie. 82: 453-68. PMID 10865132 DOI: 10.1016/S0300-9084(00)00199-1  0.72
2000 Orlova EV, Rahman MA, Gowen B, Volynski KE, Ashton AC, Manser C, van Heel M, Ushkaryov YA. Structure of alpha-latrotoxin oligomers reveals that divalent cation-dependent tetramers form membrane pores. Nature Structural Biology. 7: 48-53. PMID 10625427 DOI: 10.1038/71247  0.671
1999 Volynski KE, Nosyreva ED, Ushkaryov YA, Grishin EV. Functional expression of alpha-latrotoxin in baculovirus system. Febs Letters. 442: 25-8. PMID 9923597 DOI: 10.1016/S0014-5793(98)01624-X  0.657
Low-probability matches (unlikely to be authored by this person)
2016 Clarke RW, Novak P, Zhukov A, Tyler EJ, Cano-Jaimez M, Drews A, Richards O, Volynski K, Bishop C, Klenerman D. Low Stress Ion Conductance Microscopy of Sub-Cellular Stiffness. Soft Matter. PMID 27604678 DOI: 10.1039/C6Sm01106C  0.279
2016 Begum R, Bakiri Y, Volynski KE, Kullmann DM. Action potential broadening in a presynaptic channelopathy. Nature Communications. 7: 12102. PMID 27381274 DOI: 10.1038/ncomms12102  0.265
2017 Thalhammer A, Contestabile A, Ermolyuk YS, Ng T, Volynski KE, Soong TW, Goda Y, Cingolani LA. Alternative Splicing of P/Q-Type Ca(2+) Channels Shapes Presynaptic Plasticity. Cell Reports. 20: 333-343. PMID 28700936 DOI: 10.1016/J.Celrep.2017.06.055  0.251
2019 Tyurikova O, Nicholson E, Kullmann DM, Rusakov D, Volynski K. Tornado-FLIM acquisition for monitoring single-synapse presynaptic calcium dynamics in a mouse model of a migraine Ibro Reports. 6: S488. DOI: 10.1016/J.Ibror.2019.07.1533  0.247
2020 Banks GT, Guillaumin MCC, Heise I, Lau P, Yin M, Bourbia N, Aguilar C, Bowl MR, Esapa C, Brown LA, Hasan S, Tagliatti E, Nicholson E, Bains RS, Wells S, ... ... Volynski K, et al. Forward genetics identifies a novel sleep mutant with sleep state inertia and REM sleep deficits. Science Advances. 6: eabb3567. PMID 32851175 DOI: 10.1126/Sciadv.Abb3567  0.225
2023 Norman CA, Krishnakumar SS, Timofeeva Y, Volynski KE. The release of inhibition model reproduces kinetics and plasticity of neurotransmitter release in central synapses. Communications Biology. 6: 1091. PMID 37891212 DOI: 10.1038/s42003-023-05445-2  0.221
2023 Norman C, Krishnakumar S, Timofeeva Y, Volynski K. The release of inhibition model reproduces kinetics and plasticity of neurotransmitter release in central synapses. Research Square. PMID 37163032 DOI: 10.21203/rs.3.rs-2700789/v1  0.221
2017 Vivekananda U, Novak P, Bello OD, Korchev YE, Krishnakumar SS, Volynski KE, Kullmann DM. Kv1.1 channelopathy abolishes presynaptic spike width modulation by subthreshold somatic depolarization. Proceedings of the National Academy of Sciences of the United States of America. PMID 28193892 DOI: 10.1073/Pnas.1608763114  0.221
2022 Mendonça PRF, Tagliatti E, Langley H, Kotzadimitriou D, Zamora-Chimal CG, Timofeeva Y, Volynski KE. Asynchronous glutamate release is enhanced in low release efficacy synapses and dispersed across the active zone. Nature Communications. 13: 3497. PMID 35715404 DOI: 10.1038/s41467-022-31070-4  0.215
2015 Spillane J, Ermolyuk Y, Cano-Jaimez M, Lang B, Vincent A, Volynski KE, Kullmann DM. Lambert-Eaton syndrome IgG inhibits transmitter release via P/Q Ca2+ channels. Neurology. 84: 575-9. PMID 25589670 DOI: 10.1212/WNL.0000000000001225  0.201
2004 Elson D, Requejo-Isidro J, Munro I, McGinty J, Dunsby C, Neil M, French P, Volynski K, Kellett P, Dymoke-Bradshaw T, Hares J. Towards high-speed wide-field fluorescence lifetime imaging Biosilico. DOI: 10.1364/Bio.2004.Thc2  0.198
2013 Novak P, Gorelik J, Vivekananda U, Shevchuk AI, Ermolyuk YS, Bailey RJ, Bushby AJ, Moss GW, Rusakov DA, Klenerman D, Kullmann DM, Volynski KE, Korchev YE. Nanoscale-targeted patch-clamp recordings of functional presynaptic ion channels. Neuron. 79: 1067-77. PMID 24050398 DOI: 10.1016/J.Neuron.2013.07.012  0.189
2006 Volynski KE, Rusakov DA, Kullmann DM. Presynaptic fluctuations and release-independent depression. Nature Neuroscience. 9: 1091-3. PMID 16878129 DOI: 10.1038/nn1746  0.115
2008 Surges R, Volynski KE, Walker MC. Is levetiracetam different from other antiepileptic drugs? Levetiracetam and its cellular mechanism of action in epilepsy revisited. Therapeutic Advances in Neurological Disorders. 1: 13-24. PMID 21180561 DOI: 10.1177/1756285608094212  0.076
2018 Codner GF, Mianné J, Caulder A, Loeffler J, Fell R, King R, Allan AJ, Mackenzie M, Pike FJ, McCabe CV, Christou S, Joynson S, Hutchison M, Stewart ME, Kumar S, ... ... Volynski KE, et al. Application of long single-stranded DNA donors in genome editing: generation and validation of mouse mutants. Bmc Biology. 16: 70. PMID 29925374 DOI: 10.1186/s12915-018-0530-7  0.07
Hide low-probability matches.